8-K//Current report
VYNE Therapeutics Inc. 8-K
Accession 0001104659-25-078135
$VYNECIK 0001566044operating
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 8:05 AM ET
Size
293.0 KB
Accession
0001104659-25-078135
Documents
- 8-Ktm2523400d1_8k.htmPrimary
FORM 8-K
- EX-99.1tm2523400d1_ex99-1.htm
EXHIBIT 99.1
- EX-101.SCHvyne-20250811.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABvyne-20250811_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREvyne-20250811_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICtm2523400d1_ex99-1img01.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-25-078135-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLtm2523400d1_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566044
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 8:05 AM ET
- Size
- 293.0 KB